EcoDrugPlus

Retinoic Acid Receptor Alpha

Ensembl ID : ENSMAUG00000014473
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSMAUG00000000652
Gene Symbol: RARB
2 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSMAUG00000020715
Gene Symbol: RARG
3 Cross references
446 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSMAUG00000016806
Gene Symbol: RXRA
3 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSMAUG00000009043
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSMAUG00000019514
Gene Symbol: RXRG
4 Cross references
273 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSMAUG00000016402
Gene Symbol: RPL13A
3 Cross references
159 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSMAUG00000014583
Gene Symbol: RPL14
3 Cross references
250 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSMAUG00000013578
Gene Symbol: RPL18
4 Cross references
180 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSMAUG00000001047
Gene Symbol: RPL22
4 Cross references
89 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSMAUG00000013489
Gene Symbol: RPL24
3 Cross references
298 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSMAUG00000009257
Gene Symbol: RPL26
3 Cross references
139 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).